SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001104659-23-009352
Filing Date
2023-02-01
Accepted
2023-02-01 17:30:31
Documents
2
Period of Report
2023-01-30

Document Format Files

Seq Description Document Type Size
1 OWNERSHIP DOCUMENT tm235142-1_4seq1.html 4  
1 OWNERSHIP DOCUMENT tm235142-1_4seq1.xml 4 6855
2 POWER OF ATTORNEY tm235142-1_ex24.htm EX-24 8570
  Complete submission text file 0001104659-23-009352.txt   17026
Mailing Address 910 CLOPPER ROAD SUITE 201S GAITHERSBURG MD 20878
Business Address 910 CLOPPER ROAD SUITE 201S GAITHERSBURG MD 20878 2406541450
Altimmune, Inc. (Issuer) CIK: 0001326190 (see all company filings)

IRS No.: 202726770 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations

Mailing Address C/O ALTIMMUNE, INC. 910 CLOPPER ROAD, SUITE 201S GAITHERSBURG MD 20878
Business Address
Harris Matthew Scott (Reporting) CIK: 0001787762 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-32587 | Film No.: 23577969